The patient is diagnosed with type 2 diabetes. The diagnosis is definitive, indicated by an HbA1c level of 6 and fasting blood sugar of 115. The patient has a BMI of 35. Insulin is being used, along with 8.5 mL of metformin and a sulfonylurea for additional anti-diabetic treatment. Dietary restrictions involve periodic fasting, and the patient engages in 500 meters of daily walking for exercise. There is no history of ketoacidosis, and comorbidities are absent, except for a stroke event in the previous year.
